============================================================
ğŸ“Š BIOCON FDA PROJECT - MODEL TRAINING REPORT
Generated: 2025-07-01 01:40:30
============================================================

ğŸ“Š Data Overview:
   Training Samples: 2,072
   Test Samples: 518
   Features Used: ['Close', 'Volume']
   Date Range: 2015-01-01 to 2025-06-30
   Target: 5-Day Forward Return

ğŸ§  Model Performance:
   RandomForest:
     Train RÂ²: 0.4581
     Test RÂ²: -0.1098
     Train Adjusted RÂ²: 0.4576
     Test Adjusted RÂ²: -0.1141
     Train MSE: 0.001094
     Test MSE: 0.002693
     CV RÂ² Mean: -0.9853 (Â±0.8480)

   XGBoost:
     Train RÂ²: 0.4017
     Test RÂ²: -0.1129
     Train Adjusted RÂ²: 0.4011
     Test Adjusted RÂ²: -0.1172
     Train MSE: 0.001208
     Test MSE: 0.002701
     CV RÂ² Mean: -0.7547 (Â±0.6253)

   LinearRegression:
     Train RÂ²: 0.0151
     Test RÂ²: 0.0103
     Train Adjusted RÂ²: 0.0142
     Test Adjusted RÂ²: 0.0065
     Train MSE: 0.001989
     Test MSE: 0.002402
     CV RÂ² Mean: -0.3325 (Â±0.6413)

ğŸ“ˆ Analysis:
   Best Model: LinearRegression (Test Adjusted RÂ²: 0.0065)
   Adjusted RÂ² accounts for the number of features, providing a robust measure of model fit.
   Lower MSE indicates better prediction accuracy.
   Models use available stock and sentiment data.

ğŸ¯ Top Features (Random Forest):
     Close: 0.6089
     Volume: 0.3911

ğŸ“ Outputs:
   âœ… predictions.csv
   âœ… feature_importance.csv
   âœ… performance_report.txt
   âœ… charts/model_performance.png
   âœ… charts/predictions_vs_actual.png
   âœ… charts/feature_importance.png
   âœ… charts/stock_price.png
============================================================